Hagerman, R. J. & Hagerman, P. J. In Physical and behavioral phenotype (eds. Hagerman, R. J. & Cronister, A.) pp.3-109 (John Hopkins University Press, Baltimore, 2002).
Bagni, C. & Greenough, W. T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6, 376–387 (2005).
Laggerbauer, B., Ostareck, D., Keidel, E. M., Ostareck-Lederer, A. & Fischer, U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10, 329–338 (2001).
Li, Z. et al. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29, 2276–2283 (2001).
-High-Quality-100x70.jpg "Commentary on Breakthrough COVID-19 Infections from Brett Elicker, MD")
